Po Wen Wu
Vorstandsvorsitzender bei Polaris Pharmaceuticals, Inc.
Profil
Po Wen Wu is currently the President & Chief Executive Officer at Polaris Pharmaceuticals, Inc. and the Chairman & Chief Executive Officer at Designerx Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at DRX USA, DRX Chengdu, and TDW Pharmaceuticals, Inc. Additionally, he serves as a Director at DesigneRx Europe Ltd., DRX SHANGHAI, and DRX Hong Kong.
In the past, he was the President & Chief Executive Officer at Polaris Group, Inc. from 2011 to 2013 and the Chairman & General Manager at Polaris Group.
Dr. Wu holds a doctorate degree from the University of California, Berkeley.
Aktive Positionen von Po Wen Wu
| Unternehmen | Position | Beginn |
|---|---|---|
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | - |
| DesigneRx Europe Ltd. | Direktor/Vorstandsmitglied | - |
| Designerx Pharmaceuticals, Inc. | Vorstandsvorsitzender | - |
| DRX USA | Vorstandsvorsitzender | - |
| TDW Pharmaceuticals, Inc. | Vorstandsvorsitzender | - |
| DRX Chengdu | Vorstandsvorsitzender | - |
| DRX SHANGHAI | Direktor/Vorstandsmitglied | - |
| DRX Hong Kong | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Po Wen Wu
| Unternehmen | Position | Ende |
|---|---|---|
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | Präsident | 06.03.2013 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Po Wen Wu
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Polaris Group, Inc.
Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | Finance |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| TDW Pharmaceuticals, Inc. | |
| DesigneRx Europe Ltd. | |
| Designerx Pharmaceuticals, Inc. | |
| DRX USA | |
| DRX Chengdu | |
| DRX SHANGHAI | |
| DRX Hong Kong |
